Director, Global Scientific Communications
As the Director, Global Scientific Communications, Dr. Benmaamar reviews, analyzes, and disseminates key scientific data that are critical to the success of the Foundation’s research and innovation programs, which are aimed at accelerating smoking cessation and harm reduction. She develops scientific communication strategies and ensures accurate scientific messaging.
Prior to joining the Foundation, Dr. Benmaamar was Manager of Global Publications and Scientific Communications, Oncology Business Group, at Eisai Pharmaceuticals. She managed the global communication of the results of clinical trials, and the review process of scientific and medical documents prior to their publication in peer-review journals and their presentation at scientific meetings.
Before working at Eisai, Dr. Benmaamar was Senior Researcher at New York University, Langone Medical Center, Radiation Oncology. She managed pancreatic cancer research. She helped design innovative research projects to better understand the various molecular, immunological, and metabolic aspects of pancreatic cancer. In earlier years, Dr. Benmaamar was Associate Director of Medical Communications at medical communication agencies, partnering with pharmaceuticals to develop scientific content for presentations at conferences and advisory boards, and for patient and healthcare provider websites.
In addition to her scientific experience, Dr. Benmaamar worked at the United Nations as a Conference Manager. She facilitated and coordinated a wide range of conferences such as those of the World Health Organization (WHO), United Nations Children’s Fund (UNICEF), Human Rights Committee, General Assembly, Indigenous Peoples’ Forum, and Conference of the Parties (COP 20) to the United Nations Framework Convention on Climate Change. She speaks four of the six United Nations official languages (English, French, Arabic, and Spanish), as well as Italian.
Dr. Benmaamar is a seasoned freelance writer for The Lancet Oncology, mainly communicating groundbreaking results of clinical trials on several types of cancer. She holds a PhD in Pharmacology from Univerisité Louis Pasteur, Strasbourg, France.
POSTS BY AUTHOR
Morven Summary (PDF) Participants of the Morven Dialogue that was held in November 2018 identified 10 Core Principles that aim to guide ongoing and future discussions for the development and implementation of effective policies and objectives on harm reduction. We outline the position of the Foundation for a Smoke-Free World (herein referred to as “The […]
Mission is to eliminate smoking worldwide by supporting cessation & harm reduction #research, and transitioning tobacco #farmers to alternative livelihoods.
At today's #AgTechChallenge, 33 next-generation inventors from #Malawi presented prototypes for solutions to challenges facing smallholder farmers. Renowned author @wkamkwamba and our president Derek Yach were two of the judges evaluating the competition. #ATISummit2019
Tomorrow at the #ATISummit2019 in #Malawi the role of inclusive science, technology, and innovation in driving agricultural transformation will be explored. We look forward to another engaging event. http://bit.ly/2NMqwMa
Tomorrow we kick off the second annual #ATISummit2019 where thought leaders from international delegations, local government and private & farming sectors will convene as part of the ATI’s commitment to economic diversification in #Malawi. To learn more: http://bit.ly/2OamVYm
Ahead of the #ATISummit2019, our President Derek Yach reflects on the progress made in #Malawi over the past year. Hear about highlights. http://bit.ly/2NMqwMa
Our President Derek Yach and Vice President of Industry Transformation and Finance David Janazzo discuss how the “CREATIVE DESTRUCTION OF LEGACY INDUSTRIES GIVES BIRTH TO MORE SUSTAINABLE ONES”. Read the full piece: https://bit.ly/33O8HmA
Sign up with your email address to receive news and updates